Colon Cancer
Recent findings in colon cancer described by researchers from Palacky University, Medical Department
Published in Disease Risk Factor Week, February 28th, 2010
"Targeted agents present with a new spectrum of side-effects, including toxicities that negatively impact the risk of atherosclerosis. The aim of the present study was to evaluate the effect of the combination of targeted therapy and chemotherapy on serum homocysteine and other laboratory parameters of cardiovascular risk in patients with metastatic colorectal carcinoma," scientists in Olomouc, Czech Republic report.
"Thirty-one patients with metastatic colorectal carcinoma treated with the combination of bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin were studied before and during the therapy. Serum homocysteine decreased significantly throughout the course of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Acid Reflux Disease Gene Therapy
New research on acid reflux disease gene therapy from Brown University summarized - Acute Coronary Syndrome
Scientists at Medical University of Silesia target acute coronary syndrome - Addiction Medicine
Research from University of Texas Southwestern Medical Center, Department of Psychiatry provides new data about addiction medicine - Addiction Medicine
Studies from Brock University update current data on addiction medicine - Addiction Medicine
Studies from Karolinska Institute, Department of Clinical Neuroscience provide new data on addiction medicine - Age and Aging
Data on age and aging described by researchers at Chinese University of Hong Kong - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
